Nutex Health Inc. (NUTX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Nutex Health Inc. (NUTX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 80/100 — a percentile rank of Nutex Health Inc.’s fundamentals against Services peers, weakest on management. A quality ranking, not a price prediction.
| Market cap | $1.5B |
| P / E | 8.1× |
| P / S | 1.7× |
| EV / EBITDA | 4.1× |
| Gross margin | 100.0% |
| Operating margin | 43.0% |
| Net margin | 32.2% |
| Return on equity | 45.6% |
| ROIC | 46.8% |
| Revenue growth | 6.9% |
| Debt / equity | 0.8× |
| Dividend yield | 1.3% |
Is Nutex Health Inc. overvalued? P/S looks overvalued vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks overvalued vs its 5-year range.
Independent of the events above — derived from Nutex Health Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact